ArticleFrontiers in medicine2026
ANGPTL2 overexpression promotes angiogenic responses in human retinal microvascular endothelial cells with accompanying integrin α5β1 molecular changes.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic retinopathy (DR) is a leading cause of preventable vision loss worldwide, characterized by retinal microvascular dysfunction and progressive angiogenic dysregulation. Angiopoietin-like protein 2 (ANGPTL2) promotes endothelial activation and pathological angiogenesis in multiple vascular disease contexts, yet its effects on retinal endothelial angiogenic behavior have not been directly characterized. Whether integrin α5β1 and PI3K/AKT phosphorylation changes in the diabetic retina are associated with alterations in ANGPTL2 expression levels also remains unexamined. Methods: ANGPTL2 was overexpressed in human retinal microvascular endothelial cells (HRMECs), and effects on cell viability, wound closure, invasion, and tube formation were assessed by CCK-8, wound healing, Transwell invasion, and tube formation assays. Integrin α5β1, VEGF, and PI3K/AKT phosphorylation were characterized by western blot. Retinal tissues from streptozotocin (STZ)-induced diabetic rats across groups with varying ANGPTL2 expression levels were analyzed by RT-qPCR, western blot, and immunofluorescence to characterize accompanying molecular changes. The protein-level association between ANGPTL2 and integrin α5β1 was examined by co-immunoprecipitation and co-localization immunofluorescence under overexpression conditions. Results: ANGPTL2 overexpression significantly enhanced cell viability, wound closure, invasion, and tube formation in HRMECs, accompanied by upregulation of VEGF, p-VEGFR2, integrin α5β1, and PI3K/AKT phosphorylation. Retinal tissues from STZ-diabetic rats showed elevated integrin α5β1 expression, increased CD31 levels, and increased PI3K/AKT phosphorylation relative to non-diabetic controls; these molecular changes were directionally lower in the ANGPTL2 knockdown comparison group (i.e., the STZ + sh-ANGPTL2 group), providing supportive retinal molecular context. Co-immunoprecipitation and co-localization analyses indicated a protein-level association between ANGPTL2 and integrin α5β1 under overexpression conditions. Conclusion: ANGPTL2 overexpression promotes angiogenic responses in retinal endothelial cells
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.